X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

LSPedia and Pharma Logistics Announce Strategic Partnership to Revolutionize Pharmaceutical Reverse Logistics and Supply Chain Visibility

Content Team by Content Team
19th August 2024
in Packaging & Logistic, Press Statements
COVID-19: big pharma confident on supply chain integrity

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

LSPedia, a SaaS solution leader in global product traceability, proudly announces a strategic partnership with Pharma Logistics, the industry leader in pharmaceutical reverse distribution. This collaboration aims to transform the pharmaceutical supply chain by offering turnkey compliance, unprecedented data visibility, and robust supply chain efficiency.

Compliance is at the core of Pharma Logistics’ business model, aligning with the broader industry goal of enhancing healthcare affordability and ensuring the compliant handling of pharmaceuticals. With rigorous processes, Pharma Logistics ensures that pharmaceutical products are handled efficiently and safely throughout their end-of-life cycle providing customers with unmatched visibility, simplified returns, and actionable insights.

Expanded Value for Combined Customer Base

This partnership enhances value for the combined customer base of both companies. The integrated solution enables health systems, pharmacies, and other stakeholders to access a comprehensive 360-degree view of the pharmaceutical supply chain, from manufacturing to end-of-life processing. For the first time, pharmaceutical companies can rely on a single, trusted source of information to make informed business decisions faster and with greater confidence.

“We are delighted to offer LSpedia’s OneScan solution to our pharmacy customers. Our customers have consistently highlighted the challenge of managing complex DSCSA compliance requirements and ensuring accurate product traceability. By integrating OneScan, we are addressing these critical pain points and making advanced compliance technology more accessible,” said David A. Hargraves, CEO of Pharma Logistics. “This partnership enables us to provide a more seamless, efficient, and reliable solution, empowering our customers to stay ahead in the ever-evolving regulatory landscape.”

Value Beyond Compliance by OneScan Solution

LSPedia’s OneScan solution is the leading platform for achieving complete compliance with the FDA’s DSCSA regulations. It delivers to customers a transparent view of the pharmaceutical supply chain with real-time product tracing data at the serial, lot, order, and NDC level. When seamlessly integrated with the hospital and pharmacy systems, the innovative platform significantly reduces redundant product scanning across various systems, streamlines complex recall management, and mitigates the risk of drug shortages.

“Our partnership with Pharma Logistics represents a significant step forward in our mission to enhance pharmaceutical supply chain compliance and operations,” said Riya Cao, CEO of LSPedia. “We are thrilled to work with such a respected leader in reverse logistics and to offer our combined expertise to benefit the entire industry.”

Previous Post

Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb

Next Post

Clario joins forces with Mobilise-D to advance Digital Mobility Outcomes in clinical trials

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
Future Trends Shaping
Packaging & Logistic

Future Trends Shaping Pharma Supply Chain and Logistics

30th July 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Next Post
Employee – Driven Digital Transformation In Life Science

Clario joins forces with Mobilise-D to advance Digital Mobility Outcomes in clinical trials

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In